BioSig Technologies (BSGM) Corporate Presentation from NobleCon18Research, News and Market Data on BioSig TechnologiesNobleCon 18 Complete Rebroadcast
|
Take it to the next level. It doesn’t cost a penny.
Join the Channelchek Investor Community. Your name, email, zip, and investor type is all it takes to open the door to research reports, favorites tracking, and virtual and in-person roadshows / conferences. Even exclusive investment opps.
‌
Welcome to the Channelchek Investor Community
We’ve updated the entire site to bring you faster navigation and increased content at every level. Channelchek is now North America’s leading platform for access to regulated and independent company sponsored equity research.
Don't have an account? Join
Forgot passwordBy clicking “Log In” you agree to Channelchek.com Terms of Use and acknowledge that Channelchek.com Privacy Policy applies to you.
Related News
‌
4/30/2024
Health
ZyVersa Therapeutics, Inc. (ZVSA) – Inflammation Study Links Alzheimer’s Disease With Chronic Heart Disease
New Study On Inflammasomes Connects Alzheimer’s Disease With Cardiovascular Disease. Research published in a peer-reviewed journal has shown that Alzheimer’s disease produces inflammasome components that can lead a systemic response, including...
2 min read
‌
4/30/2024
Natural Resources
Century Lithium Corp. (CYDVF) – Clayton Valley Feasibility Study Sets the Stage for Commercialization
Results of the Clayton Valley feasibility study. Century released the results of a feasibility study (FS) for its Clayton Valley lithium project in Nevada. A phased approach was adopted. Phase I...
2 min read
‌
4/30/2024
Health
X4 Pharmaceuticals Hits Jackpot With Xolremdi Approval, Unlocking M&A Potential
In a significant value-creating event, X4 Pharmaceuticals has secured FDA approval for its lead drug Xolremdi, ushering the biotech into the commercial realm and positioning it as an attractive M&A...
3 min read
Inbox Intel from Channelchek.
Informed investors make more money. And it’s all about timing. Get it when it happens.